우리바이오

082850KOSDAQ

67.6 / 100

Reference Date: 2026-09-08

Financial Score20.0 / 40

News Sentiment21.6 / 25

Momentum16.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Surged 523.5% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Ourbio operates five business segments, including health functional foods, FPCB and electronic components, LED modules, real estate, and nanofiber fabrics. It is actively expanding its health functional food market through brands like 'Solutio' and 'Harutin,' while the FPCB segment benefits from growing demand in smart devices and automotive industries. The company is also expanding into bio-related fields, such as medical cannabis research.

Number of Employees

95people

Average Salary

45.9M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

0.22Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE

-3.84Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

18.87Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20251.0 / 10 points

Revenue Growth Rate

0.0 / 3

Avg ▼8.9% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼67.6% (2-year basis)

ROE Trend

1.0 / 4

Avg ROE 2.4% (declining, 3yr)

Detailed News Sentiment

4 totalPositive 4Neutral 0Negative 0Average Sentiment Score 86.2

Positive
우리바이오, 액면병합 후 거래 재개 첫날 ‘上’[특징주]
우리바이오의 액면병합 후 거래 재개 첫날 상한가 기록으로 긍정적인 시장 반응 확인.
Positive
"K팝처럼 K건기식 띄울 것" 동남아 공략나선 우리그룹
우리바이오 관련 우리그룹의 글로벌 마케팅 강화로 인해 K건기식 시장에서의 성장 기대감 증가.
Positive
“K팝처럼 K바이오도 통한다”…동남아 정조준한 우리그룹
우리바이오의 리포좀 기술이 아시아 주요 전시회에서 주목받아 고객사들의 관심과 상담이 증가하며 수출 확대 기대감이 높아졌다.

Detailed Momentum

52-week position8.0Point

Near 52w high (100%, uptrend)

Current 5,830Won52-week high 5,83052-week low 859

1-month return6.0Point

1m +523.53% (strong rise)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0

Neutral주권매매거래정지해제 (액면병합 주권 변경상장)2026-09-04
Neutral반기보고서 (2026.06)2026-08-14
Neutral주권매매거래정지 (주식의 병합, 분할 등 전자등록 변경, 말소)2026-08-11